Literature DB >> 19388157

Inherited complement deficiencies and bacterial infections.

Francesco Tedesco1.   

Abstract

A wide variety of bacteria are recognized by the complement system through the early components that trigger the three pathways of complement activation, leading to the release of biologically active products involved in opsonization, recruitment of phagocytes and bacterial killing. Deficiencies of complement components and regulators provide a model to understand the in vivo role of complement as a defense system against bacterial infections. An increased susceptibility to these types of infections is frequently seen in individuals with C2, C3, late component, properdin and factor I deficiencies. The identification of these deficiencies is essential for the adoption of preventive measures aimed to reduce the risk of bacterial infections. Vaccination represents the treatment of choice to protect these subjects, although further studies on a large number of C-deficient individuals are needed to prove the protective effect of vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19388157     DOI: 10.1016/j.vaccine.2008.11.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

Review 2.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

3.  Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).

Authors:  Maguy Daures; Michele John; Cécile Veysseyre Balter; Olivier Simon; Yann Barguil; Isabelle Missotte; Jean-Paul Grangeon; Sylvie Laumond-Barny; Martine Noel; Laurent Besson-Leaud; Pierre-Emmanuel Spasic; Aurélie de Suremain; Ann-Claire Gourinat; Elodie Descloux
Journal:  J Clin Immunol       Date:  2014-10-29       Impact factor: 8.317

4.  Molecular composition of the alveolar lining fluid in the aging lung.

Authors:  Juan I Moliva; Murugesan V S Rajaram; Sabeen Sidiki; Smitha J Sasindran; Evelyn Guirado; Xueliang Jeff Pan; Shu-Hua Wang; Patrick Ross; William P Lafuse; Larry S Schlesinger; Joanne Turner; Jordi B Torrelles
Journal:  Age (Dordr)       Date:  2014-03-03

5.  Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.

Authors:  Paolo G V Martini; Lynette C Cook; Scott Alderucci; Angela W Norton; Dianna M Lundberg; Susan M Fish; Knut Langsetmo; Göran Jönsson; Christian Lood; Birgitta Gullstrand; Kate J Zaleski; Nancy Savioli; Jason Lottherand; Charles Bedard; John Gill; Michael F Concino; Michael W Heartlein; Lennart Truedsson; Jan L Powell; Arthur O Tzianabos
Journal:  BMC Immunol       Date:  2010-08-20       Impact factor: 3.615

6.  Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis.

Authors:  Hiroyuki Inoshita; Isao Ohsawa; Gaku Kusaba; Masaya Ishii; Kisara Onda; Satoshi Horikoshi; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2010-12-06       Impact factor: 2.388

7.  Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

8.  Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein.

Authors:  Declan T Bradley; Thomas W Bourke; Derek J Fairley; Raymond Borrow; Michael D Shields; Peter F Zipfel; Anne E Hughes
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  First Necrotizing Fasciitis Caused by Haemophilus influenza Serotype a.

Authors:  Giang T Quach; Jared Frisby; Kurt Kralovich; Mustafa Bohra
Journal:  J Investig Med High Impact Case Rep       Date:  2017-10-25

Review 10.  Yersinia pestis Ail: multiple roles of a single protein.

Authors:  Anna M Kolodziejek; Carolyn J Hovde; Scott A Minnich
Journal:  Front Cell Infect Microbiol       Date:  2012-08-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.